Tough Mudder 2026
With various events to choose from in 2026, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Search results
With various events to choose from in 2026, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Tribute to Retina UK founder Lynda Cantor MBE
KIO-301, an experimental ‘photoswitch’ drug in development by Kiora Pharmaceuticals has shown encouraging safety results in early-stage testing and is now being evaluated in a phase 2 study known as ABACUS-2. It is currently being trialled in those with advanced RP, with the potential to expand into choroideremia and stargardt disease.
X-linked inheritance means that the faulty gene is located on the X chromosome, the larger of the two sex chromosomes.
Information for healthcare professionals: Genetic testing and counselling in inherited retinal disease
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
The collective partnership of eight of the leading charities in the sight loss sector, known for the last three years as the VI Charity Sector Partnership, has re-launched under a new identity of the ‘Vision Partnership’ with a re-invigorated purpose and new strategic focus.
Join us for our upcoming webinar!
Tickle everyone’s taste buds and help raise funds for Retina UK with our Great Bake fundraiser!
Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.